Prana Biotechnology Ltd., of Melbourne, Australia, said it entered a securities purchase agreement for a lead investment by Life Biosciences LLC, of Boston, to raise up to approximately AU$44.5 million (US$31.4 million). It will initially invest $7.5 million, with the agreement allowing the company to raise an additional $2 million from other investors.